Anteris Technologies Past Earnings Performance
Past criteria checks 0/6
Anteris Technologies's earnings have been declining at an average annual rate of -44.4%, while the Medical Equipment industry saw earnings growing at 8.3% annually. Revenues have been declining at an average rate of 35.3% per year.
Key information
-44.4%
Earnings growth rate
-17.2%
EPS growth rate
| Medical Equipment Industry Growth | 5.8% |
| Revenue growth rate | -35.3% |
| Return on equity | -1,952.3% |
| Net Margin | -2,260.9% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Shareholders May Not Be So Generous With Anteris Technologies Ltd's (ASX:AVR) CEO Compensation And Here's Why
May 22
Increases to CEO Compensation Might Be Put On Hold For Now at Anteris Technologies Ltd (ASX:AVR)
Jul 08Increases to Anteris Technologies Ltd's (ASX:AVR) CEO Compensation Might Cool off for now
May 07Does Anteris Technologies' (ASX:AVR) CEO Salary Compare Well With The Performance Of The Company?
Feb 21
Anteris Technologies Ltd (ASX:AVR) Insiders Have Been Selling
Dec 10Revenue & Expenses Breakdown
How Anteris Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 4 | -88 | 55 | 37 |
| 31 Mar 24 | 4 | -78 | 51 | 30 |
| 31 Dec 23 | 4 | -67 | 46 | 23 |
| 30 Sep 23 | 4 | -60 | 43 | 20 |
| 30 Jun 23 | 4 | -52 | 39 | 17 |
| 31 Mar 23 | 5 | -48 | 37 | 15 |
| 31 Dec 22 | 5 | -44 | 34 | 13 |
| 30 Sep 22 | 6 | -40 | 31 | 12 |
| 30 Jun 22 | 7 | -35 | 27 | 11 |
| 31 Mar 22 | 7 | -29 | 23 | 10 |
| 31 Dec 21 | 8 | -23 | 19 | 8 |
| 30 Sep 21 | 7 | -21 | 18 | 7 |
| 30 Jun 21 | 6 | -20 | 16 | 6 |
| 31 Mar 21 | 7 | -17 | 16 | 5 |
| 31 Dec 20 | 7 | -15 | 17 | 5 |
| 30 Sep 20 | 9 | -8 | 21 | 4 |
| 30 Jun 20 | 10 | 0 | 26 | 4 |
| 31 Mar 20 | 14 | -3 | 28 | 4 |
| 31 Dec 19 | 17 | -6 | 30 | 3 |
| 30 Sep 19 | 20 | -15 | 30 | 3 |
| 30 Jun 19 | 24 | -24 | 30 | 3 |
| 31 Mar 19 | 25 | -24 | 30 | 3 |
| 31 Dec 18 | 26 | -24 | 30 | 3 |
| 31 Dec 17 | 23 | -17 | 26 | 1 |
| 30 Jun 17 | 22 | -12 | 20 | 2 |
| 31 Mar 17 | 21 | -15 | 21 | 2 |
| 31 Dec 16 | 20 | -18 | 21 | 3 |
| 30 Sep 16 | 17 | -21 | 23 | 4 |
| 30 Jun 16 | 14 | -24 | 24 | 5 |
| 31 Mar 16 | 13 | -26 | 23 | 5 |
| 31 Dec 15 | 12 | -27 | 23 | 4 |
| 30 Sep 15 | 11 | -26 | 21 | 3 |
| 30 Jun 15 | 10 | -25 | 19 | 3 |
| 31 Mar 15 | 9 | -21 | 17 | 2 |
| 31 Dec 14 | 9 | -17 | 15 | 2 |
| 30 Sep 14 | 8 | -12 | 13 | 2 |
| 30 Jun 14 | 8 | -7 | 11 | 2 |
| 31 Mar 14 | 8 | -4 | 10 | 2 |
| 31 Dec 13 | 8 | -1 | 9 | 1 |
Quality Earnings: AVR is currently unprofitable.
Growing Profit Margin: AVR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AVR is unprofitable, and losses have increased over the past 5 years at a rate of 44.4% per year.
Accelerating Growth: Unable to compare AVR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AVR is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (18.7%).
Return on Equity
High ROE: AVR has a negative Return on Equity (-1952.28%), as it is currently unprofitable.